MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Moleculin Biotech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.27−0.02 (-5.49%)
Close on Oct 19, 2026
- Market cap
- $1.51M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Moleculin Biotech's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2026 | Oct 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Aug 31, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 9, 2026 | Aug 24, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jun 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jun 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 22, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 15, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 14, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 18, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 15, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |